ReSViNET
  • Home
  • News
  • Conferences
    • 5th Meeting 2019
    • 4th Meeting 2017
    • 3rd Meeting 2017
    • 2nd Expert Meeting
    • 1st Expert Meeting
  • parents
  • professionals
  • about
    • The foundation
    • Global network
    • Mission Statement
    • Board members
    • Partners
  • patient network
  • Publications
  • contact us

Click here to edit.

Virus inhibitor step towards treatment of Respiratory Syncytial Virus 

9/18/2014

0 Comments

 
DeVincenzo JP, et al.

American researchers published positive results with GS-5806, a novel antiviral that inhibits the activity of respiratory syncytial virus (RSV). The orally administered fusion inhibitor was effective during a placebo-controlled challenge study where healthy adults were experimentally infected with the well-characterized Memphis-37b strain.

John DeVincenzo, associated with the Le Bonheur Children's Hospital (Memphis, TN, USA), and colleagues found that administration of GS-5086 at 2-5 days after infection prevented mucus production, respiratory symptoms, and subsequent development of high viral loads. Peak viral loads were 3-4 logs lower in treated participants. No signs of toxicity were observed. This study is a major step forward towards a treatment for patients with RSV infection.
Download file
0 Comments



Leave a Reply.

    CATEGORIES

    All
    ReSViNET Publications


    ARCHIVES

    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    April 2018
    December 2017
    May 2017
    March 2017
    February 2017
    September 2016
    June 2016
    March 2016
    November 2015
    October 2015
    September 2015
    June 2015
    May 2015
    April 2015
    March 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014


    RSS Feed

Note: All information on ReSViNET is for educational purposes only. For specific medical advice, diagnoses, and treatment, consult your doctor.

2018 ReSViNET. All rights reserved.
about us
disclosure
contact
  • Home
  • News
  • Conferences
    • 5th Meeting 2019
    • 4th Meeting 2017
    • 3rd Meeting 2017
    • 2nd Expert Meeting
    • 1st Expert Meeting
  • parents
  • professionals
  • about
    • The foundation
    • Global network
    • Mission Statement
    • Board members
    • Partners
  • patient network
  • Publications
  • contact us